Menopause – Breast Cancer
Breast cancer affects one in eight women during their lives and kills more women in the United States than any cancer except lung cancer. No one knows why some women get it, but there are a number of risk factors.
Breast cancer is a cancer that starts in the cells of the breast in men and women. Worldwide it is the second most common type of cancer after lung cancer (10.4% of all cancer incidence, both sexes counted) and the fifth most common cause of cancer death.
One of the best ways to deal with breast cancer (before and after diagnosis) is to gain as much knowledge (especially early symptoms, signs and causes) as possible.
There are many thousands of women suffering from breast cancer and who face the associated medical treatment that follows diagnosis. In addition to this, there are many more women who suffer from the fear of contracting the disease.
To avoid unnecessary anxiety (in addition to becoming knowledgeable on the topic) it is important to establish a positive mental attitude, and to maintain an over-all healthy lifestyle, which can lead to greater awareness and self-confidence.
Additionally, it is important to avoid as many of the factors (as possible) that are likely to lead to elevated cancer risks, starting with all the recognized carcinogens, and to learn more about other potential dangers.
Women of menopausal age who take HRT (hormone replacement therapy) put themselves at a greater risk of developing breast cancer.
One of the primary reasons that menopause and breast cancer inspires so much fear and anxiety are the catastrophic treatment plans associated with the disease.
At the top of this list are surgery (full or partial mastectomy or reconstruction), chemotherapy, and radiation.
Women are turning to more natural alternatives in the hope to either ward of the disease entirely, or to mitigate the chances of cancer cells developing and/or metastasizing.
German researchers who recently reevaluated the efficacy and effectiveness of concentrated flax hull lignans as antagonists against menopause and breast cancer, met with a high level success.
The May 10, 2010 article found in the “American Journal of Clinical Nutrition” reporting on a study conducted by the Unit of Genetic Epidemiology Division of Cancer Epidemiology German Cancer Research Center Heidelberg Germany the Institute of Epidemiology Helmholtz Centre Munich Nuremberg Germany concluded in an analysis of “lignans in relation to breast cancer risks” that a high (regular) lignan intake was associated with a “significant reduced risk of breast cancer” in postmenopausal women.
Menopause – Breast Cancer